Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tolosa

Showing results (11-20 of 430) with videos related to

Pageof 43
Sort By:
Neuropharmacology|August 1, 1997
Striatal synaptophysin levels are not indicative of dopaminergic supersensitivityC Marin, E Tolosa
Clinical Neuropharmacology|January 1, 1994
Mid-stage parkinsonism with mild motor fluctuationsE Tolosa, F Valldeoriola
Medicina Clinica|June 30, 1984
[Senile dementia: arteriosclerosis or Alzheimer disease?]E Tolosa, J Santamaría
Neurologia (Barcelona, Spain)|May 2, 2003
[Cabergoline in the treatment of Parkinson's disease]P Pastor, E Tolosa
Neuroimmunomodulation|January 7, 1999
Thymus-derived glucocorticoids and the regulation of antigen-specific T-cell developmentE Tolosa, J D Ashwell
Revista De Saude Publica|April 1, 1991
[Evaluation of working conditions of municipal employees engaged in manual labor]D E Tolosa, R Mendes
Medicina Clinica|March 15, 1986
[Idiopathic facial paralysis]M J Martí, E Tolosa
European Journal of Neurology|August 9, 2011
Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's diseaseE Tolosa, M B Stern
European Journal of Neurology|June 22, 2010
Cognition in essential tremor: should we worry about progressive cognitive decline?E Tolosa, J L Molinuevo
Advances in Neurology|January 1, 1988
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspectsE Tolosa, M J Martí
Pageof 43

Showing results (11-20 of 430) with videos related to

Sort By:
Pageof 43
Neuropharmacology|August 1, 1997
Striatal synaptophysin levels are not indicative of dopaminergic supersensitivityC Marin, E Tolosa
Clinical Neuropharmacology|January 1, 1994
Mid-stage parkinsonism with mild motor fluctuationsE Tolosa, F Valldeoriola
Medicina Clinica|June 30, 1984
[Senile dementia: arteriosclerosis or Alzheimer disease?]E Tolosa, J Santamaría
Neurologia (Barcelona, Spain)|May 2, 2003
[Cabergoline in the treatment of Parkinson's disease]P Pastor, E Tolosa
Neuroimmunomodulation|January 7, 1999
Thymus-derived glucocorticoids and the regulation of antigen-specific T-cell developmentE Tolosa, J D Ashwell
Revista De Saude Publica|April 1, 1991
[Evaluation of working conditions of municipal employees engaged in manual labor]D E Tolosa, R Mendes
Medicina Clinica|March 15, 1986
[Idiopathic facial paralysis]M J Martí, E Tolosa
European Journal of Neurology|August 9, 2011
Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's diseaseE Tolosa, M B Stern
European Journal of Neurology|June 22, 2010
Cognition in essential tremor: should we worry about progressive cognitive decline?E Tolosa, J L Molinuevo
Advances in Neurology|January 1, 1988
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspectsE Tolosa, M J Martí
Pageof 43